Clinical evaluation of pazufloxacin mesilate for chronic respiratory tract infections: Phase III comparative study of pazufloxacin mesilate versus ceftazidime
K Shimada, K Mikasa, Hiroko Kobayashi(Obayashi (Japan)), Masaru Sakamoto(Jikei University School of Medicine), Kohya Shiba, Koh‐ichi Wada, Shoichiro Irimajiri, Nozomu Kobayashi(National Cancer Center Hospital East), K. Kudo, H. Taniguchi, Tadao Nishimura, Norihiko Aoki, Yuichiro Matsuoka(Kumamoto Orthopedic Surgery Hospital), Akira Watanabe(Kyoto Prefectural University), Kingo Chida, Shinyu Izumi(Saitama International Medical Center), Takuya Fujishima, Mitsumasa Iwata, Takashi Horiuchi, S. Fukuhara, K. Konishi, Kenji Tukamoto, Bunichi Umeda, Motomichi Koyama, Akiyoshi Sato, Kuniyasu Niizuma(Tohoku University), Yuji Tohda(Kindai University Hospital), Kazuhiro Hayakawa, N. Koido, Tsuyoshi Hosoya(National Museum of Nature and Science), K. Okada, Kazuya Shirato(Tohoku University), Kazushi Suzuki(National Defense Medical College), O Sekine, S. Kawai, Takeshi Yagi, Yasuyuki Sano, Yoshitaka Nakamori, N Narita(Gifu Pharmaceutical University), Yuji Watanuki, Shosaku Abe(Sapporo Medical University), T. Nukiwa(Tohoku University), N. Tsuda, Hazimu Takeda, K Takagi, S. Odagiri, T Mitsui, Yoshifumi Noda, I Ohno, Atsushi Yoshitomi
Chemotherapy
June 25, 2000
Cited by 0
Related Papers
Double-blind, Placebo-controlled Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
|American Journal of Respiratory and Critical Care Medicine|2005|953
Nocturnal Fall of Blood Pressure and Silent Cerebrovascular Damage in Elderly Hypertensive Patients
|Hypertension|1996|620
A class-wide phylogenetic assessment of Dothideomycetes
|Studies in Mycology|2009|607
Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin–paclitaxel for chemo-naïve non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002)
|Annals of Oncology|2012|555
Eosinophilic and Noneosinophilic Asthma
|CHEST Journal|2021|262